Glucophage /Usa/ (Metformin Hydrochloride)


Combined with:

Byetta

Indications and Reactions:

Role Indications Reactions
Concomitant
Type 2 Diabetes Mellitus 89.1%
Insulin-requiring Type 2 Diabetes Mellitus 4.5%
Diabetes Mellitus 3.5%
Insulin-requiring Type Ii Diabetes Mellitus 1.3%
Drug Use For Unknown Indication 0.3%
Glucose Tolerance Impaired 0.3%
Insulin Resistant Diabetes 0.3%
Latent Autoimmune Diabetes In Adults 0.3%
Weight Decreased 0.3%
Weight Decreased 32.2%
Blood Glucose Increased 16.1%
Nausea 14.9%
Incorrect Dose Administered 6.1%
Vomiting 6.1%
Weight Increased 3.4%
Tremor 3.1%
Injection Site Haemorrhage 2.3%
Drug Ineffective 1.9%
Glycosylated Haemoglobin Increased 1.9%
Injection Site Pain 1.5%
Nervousness 1.5%
Stomach Discomfort 1.5%
Drug Effect Decreased 1.1%
Injection Site Irritation 1.1%
Injection Site Swelling 1.1%
Somnolence 1.1%
Vision Blurred 1.1%
Blood Glucose Decreased 0.8%
Decreased Appetite 0.8%

Drug Data